7BJ-53253-12728
1 vaccination
2 coded responses
7 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 891 / NV
- Registered
- 2022-03-07
- Relationship
- Child or adolescent in my care
- Guardian
- DXZ-15977-26026
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-02-28
Dose 1 — Pfizer-BioNTech
-
2022-03-07
Registered in v-safe
- 2022-03-07
- 2022-03-14
-
2022-03-24
Survey response — day 21, dose 1, dependentMedDRA: Cough, Productive cough, Wheezing — Feeling: Poor · Be unable to work or attend schoolFree text: Possible cold (?) w/ phlegm, cough and slight weezingMedDRA releases: 2024-11 · check-in free text available
- 2022-03-29
- 2022-04-13
-
2022-09-01
Survey response — 6 months, dose 1, dependentMedDRA: Nasopharyngitis, Productive cough, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Cold like; runny nose, phlegmy cough.MedDRA releases: 2024-11 · check-in free text available
- 2023-03-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-02-28 | Pfizer-BioNTech | No |
Free text
Release 11 — day 21, dose 1, dependent
Symptoms: Possible cold (?) w/ phlegm, cough and slight weezing
Release 12 — 6 months, dose 1, dependent
Symptoms: Cold like; runny nose, phlegmy cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release